Khoso Baluch - 24 Jul 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Khoso Baluch by John J. Wolfel as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Sep 2025, 16:12:36 UTC
Date Of Original Report
28 Jul 2025
Previous filing
17 Jul 2025
Next filing
13 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baluch Khoso Director C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH /s/ Khoso Baluch by John J. Wolfel as Attorney-in-Fact 18 Sep 2025 0001686223

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Award $0 +31,206 +616% $0.000000 36,275 03 Sep 2024 Common Stock 31,206 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements.
F2 Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024.

Remarks:

Amendment filed to retract the prior Form 4, which was filed in error.